Sphingomyelin Depletion Inhibits CXCR4 Dynamics and CXCL12-Mediated Directed Cell Migration in Human T Cells.
Saved in:
| Title: | Sphingomyelin Depletion Inhibits CXCR4 Dynamics and CXCL12-Mediated Directed Cell Migration in Human T Cells. |
|---|---|
| Authors: | Gardeta SR; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., García-Cuesta EM; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., D'Agostino G; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., Soler Palacios B; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., Quijada-Freire A; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., Lucas P; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., Bernardino de la Serna J; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Central Laser Facility, Rutherford Appleton Laboratory, Medical Research Council-Research Complex at Harwell, Science and Technology Facilities Council, Harwell, United Kingdom.; National Institute for Health and Care Research Imperial Biomedical Research Center, London, United Kingdom., Gonzalez-Riano C; Metabolomic and Bioanalysis Center (CEMBIO), Pharmacy Faculty, Centro de Estudios Universitarios Universities, Madrid, Spain., Barbas C; Metabolomic and Bioanalysis Center (CEMBIO), Pharmacy Faculty, Centro de Estudios Universitarios Universities, Madrid, Spain., Rodríguez-Frade JM; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., Mellado M; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Jul 12; Vol. 13, pp. 925559. Date of Electronic Publication: 2022 Jul 12 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35903108 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sphingomyelin Depletion Inhibits CXCR4 Dynamics and CXCL12-Mediated Directed Cell Migration in Human T Cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gardeta+SR%22">Gardeta SR</searchLink>; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22García-Cuesta+EM%22">García-Cuesta EM</searchLink>; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22D'Agostino+G%22">D'Agostino G</searchLink>; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Soler+Palacios+B%22">Soler Palacios B</searchLink>; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Quijada-Freire+A%22">Quijada-Freire A</searchLink>; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lucas+P%22">Lucas P</searchLink>; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bernardino+de+la+Serna+J%22">Bernardino de la Serna J</searchLink>; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Central Laser Facility, Rutherford Appleton Laboratory, Medical Research Council-Research Complex at Harwell, Science and Technology Facilities Council, Harwell, United Kingdom.; National Institute for Health and Care Research Imperial Biomedical Research Center, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Riano+C%22">Gonzalez-Riano C</searchLink>; Metabolomic and Bioanalysis Center (CEMBIO), Pharmacy Faculty, Centro de Estudios Universitarios Universities, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Barbas+C%22">Barbas C</searchLink>; Metabolomic and Bioanalysis Center (CEMBIO), Pharmacy Faculty, Centro de Estudios Universitarios Universities, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Frade+JM%22">Rodríguez-Frade JM</searchLink>; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Mellado+M%22">Mellado M</searchLink>; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Jul 12; Vol. 13, pp. 925559. <i>Date of Electronic Publication: </i>2022 Jul 12 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35903108 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2022.925559 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 925559 Titles: – TitleFull: Sphingomyelin Depletion Inhibits CXCR4 Dynamics and CXCL12-Mediated Directed Cell Migration in Human T Cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gardeta SR – PersonEntity: Name: NameFull: García-Cuesta EM – PersonEntity: Name: NameFull: D'Agostino G – PersonEntity: Name: NameFull: Soler Palacios B – PersonEntity: Name: NameFull: Quijada-Freire A – PersonEntity: Name: NameFull: Lucas P – PersonEntity: Name: NameFull: Bernardino de la Serna J – PersonEntity: Name: NameFull: Gonzalez-Riano C – PersonEntity: Name: NameFull: Barbas C – PersonEntity: Name: NameFull: Rodríguez-Frade JM – PersonEntity: Name: NameFull: Mellado M IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 07 Text: 2022 Jul 12 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |